Advances in Cas12a-Based Amplification-Free Nucleic Acid Detection
The CRISPR Journal · 2023
DOI: 10.1089/crispr.2023.0023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The CRISPR Journal, 2023. Verfasst von Shixin Ji und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Changchun Normal University, Changchun, China; and Jilin Business and Technology College, Changchun, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Nucleic Acid Amplification Techniques, CRISPR-Associated Proteins, Endodeoxyribonucleases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 67 Literaturangaben.
Abstract (Originalsprache)
In biomedicine, rapid and sensitive nucleic acid detection technology plays an important role in the early detection of infectious diseases. However, most traditional nucleic acid detection methods require the amplification of nucleic acids, resulting in problems such as long detection time, complex operation, and false-positive results. In recent years, clustered regularly interspaced short palindromic repeats (CRISPR) systems have been widely used in nucleic acid detection, especially the CRISPR-Cas12a system, which can trans cleave single-stranded DNA and can realize the detection of DNA targets. But, amplification of nucleic acids is still required to further improve detection sensitivity, which makes Cas12a-based amplification-free nucleic acid detection methods a great challenge. This article reviews the recent progress of Cas12a-based amplification-free detection methods for nucleic acids. These detection methods apply electrochemical detection methods, fluorescence detection methods, noble metal nanomaterial detection methods, and lateral flow assay. Under various optimization strategies, unamplified nucleic acids have the same sensitivity as amplified nucleic acids. At the same time, the article discusses the advantages and disadvantages of each method and further discusses the current challenges such as off-target effects and the ability to achieve high-throughput detection. Amplification-free nucleic acid detection technology based on CRISPR-Cas12a has great potential in the biomedical field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Changchun Normal University, Changchun, China; and Jilin Business and Technology College, Changchun, China.
- School of Grain, Jilin Business and Technology College, Changchun, China.
Zitieren
APA
Ji, S., Wang, X., Wang, Y., Sun, Y., Su, Y., Lv, X., & Song, X. (2023). Advances in Cas12a-Based Amplification-Free Nucleic Acid Detection. The CRISPR Journal. https://doi.org/10.1089/crispr.2023.0023
Vancouver
Ji S, Wang X, Wang Y, Sun Y, Su Y, Lv X, et al. Advances in Cas12a-Based Amplification-Free Nucleic Acid Detection. The CRISPR Journal. 2023. doi:10.1089/crispr.2023.0023
BibTeX
@article{Ji2023,
author = {Ji, Shixin and Wang, Xueli and Wang, Yangkun and Sun, Yingqi and Su, Yingying and Lv, Xiaosong and Song, Xiangwei},
title = {Advances in Cas12a-Based Amplification-Free Nucleic Acid Detection},
journal = {The CRISPR Journal},
year = {2023},
doi = {10.1089/crispr.2023.0023}
}
EUVIMED